PWAM
PROF

Park West Asset Management’s Profound Medical PROF Stock Holding History

Park West Asset Management’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-450,000
Closed -$7.94M – 137
2020
Q3 		$7.94M Buy
+450,000
New +$7.15M 0.31% 71

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Park West Asset Management's PROF Position: Q4 2020 in Review

Park West Asset Management sold out of Profound Medical (PROF) in Q4 2020, closing a stake of 450,000 shares — an estimated $7.94M sold.

Park West Asset Management first reported a position in PROF in Q3 2020 and held it in 1 quarter. The position peaked at $7.94M in Q3 2020. 56 funds tracked by Wall St. Rank hold PROF as of Q4 2020.

  • Park West Asset Management reported no remaining Profound Medical position as of Q4 2020 after selling out during the quarter.
  • Park West Asset Management sold 450,000 Profound Medical shares in Q4 2020, an estimated $7.94M.
  • Park West Asset Management first reported a position in Profound Medical in Q3 2020 and held it in 1 quarter.
  • Park West Asset Management's Profound Medical position peaked at $7.94M in Q3 2020.
  • 56 funds tracked by Wall St. Rank held Profound Medical as of Q4 2020.

Based on Park West Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.